Interview: Allan Finkel – Vice President and General…
Allan Finkel, recently voted Novo Nordisk’s best GM globally, speaks about the partnerships and projects that the Brazilian affiliate organizes with…
Tagged with insulin
Interview: Jean-François Courtet – General Manager, Novo…
Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three years, discusses the prevalence of…
Interview: Jean-François Courtet – General Manager, Novo…
Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three years, discusses the prevalence of…
Interview: Mads Stoustrup – General Manager, Novo Nordisk…
Diabetes is well managed in Switzerland’s patient-centric healthcare system, yet with new data showing Novo Nordisk’s GLP-1 has strong…
Interview: Ahmed Kelani – Managing Director, Medical Union…
Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed…
Interview: Michel Spagnol – Chairman & CEO, Novasep,…
Novasep is the largest contract manufacturer for the pharmaceuticals and fine chemicals industries in France. Michel Spagnol, the company’s chairman…
Interview: Mickey Centeno – General Manager and Head, Roche…
Miguel Centeno, general manager and head of Roche Diabetes Care in Puerto Rico, highlights the affiliate’s strong manufacturing performance in the…
Novo Nordisk – Kåre Schultz, Global President and COO
The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and…
Novo Nordisk Malaysia – Noha Shawky, General Manager
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity to raise awareness, with for…
Denver Farma – Jose Luis Tombazzi, President –…
The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of…
Interview: Glenn Saldanha, Managing Director & CEO, Glenmark
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…
